Marcellin P., e.a.: Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. In: J Hepatol. 2007 Oct;47(4):476-483, PMID 17629590.
V. K. Rusti et al.: Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.Hepatology (2009) 50(6): S. 1719–1726, PMID 19852040